Larimar Therapeutics (LRMR) Gets a Buy from JMP Securities
In a report released today, Jonathan Wolleben from JMP Securities reiterated a Buy rating on Larimar Therapeutics (LRMR – Research Report), ...
JMP Securities Keeps Their Buy Rating on Halozyme (HALO)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on Halozyme (HALO – Research Report), with a price target ...
JMP Securities Reiterates “Market Perform” Rating for Datadog (NASDAQ:DDOG)
JMP Securities reaffirmed their market perform rating on shares of Datadog (NASDAQ:DDOG – Free Report) in a research report ...
DraftKings CEO Jason Robins sells $9 million in stock
Jason Robins, CEO and Chairman of DraftKings Inc. (NASDAQ:DKNG), recently sold 200,000 shares of the company's Class A common stock, totaling approximately $9 million. The shares were sold at a ...
JMP maintains Life360 stock with $55 target, cites growth
JMP Securities maintained its Market Outperform rating on Life360 stock (NASDAQ:LIF) with a consistent price target of $55.00, representing potential upside from the current price of $46.40. The ...